Literature DB >> 6965225

Deficient strongly adherent monocytes in the peripheral blood of cancer patients.

E M Hersh1, C Gschwind, D L Morris, S Murphy.   

Abstract

The numbers of strongly adherent monocytes in the peripheral blood of normal subjects and cancer patients were determined. The method used was to place peripheral blood mononuclear cells in microwells and culture them for 1 week. At the end of that period, adherent macrophages were counted in the Coulter counter after release. Adherent cells per milliliter of blood, per total cells, and per mononuclear cells or monocytes plated were markedly diminished in the peripheral blood mononuclear cells of 44 melanoma, 23 breast cancer, 18 lung cancer, nine colon cancer, and 27 leukemia patients. Median values were 14.8 X 10(4) adherent cells per ml peripheral blood for 86 normal subjects, as against 2.5 X 10(4) per ml in the peripheral blood of the 125 patients (P less than 0.001). There was a poor correlation between the adherent cell numbers and the peripheral blood leukocyte counts, but an excellent correlation of the different adherent cell counts with each other. The number of adherent cells in the peripheral blood varied inversely with age in the cancer patients, but not in the normal subjects (r = 0.29, P less than 0.005). When patients under age 50 were compared to the controls, the deficiency of adherent cells was slightly more severe in patients with stage IV lung cancer than in those with stage III lung cancer. In contrast, there was no difference in the degree of deficiency between patients with stage III melanoma and no evident disease and patients with stage IV disseminated metastatic disease. The implications of these results are discussed.

Entities:  

Mesh:

Year:  1982        PMID: 6965225     DOI: 10.1007/BF00200177

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  18 in total

1.  Calculation of survival rates for cancer.

Authors:  J BERKSON; R P GAGE
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-05-24

2.  Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.

Authors:  B Fisher; S Taylor; M Levine; E Saffer; E R Fisher
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

3.  Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

4.  The kinetics of colony-stimulating activity elaboration from human bone marrow cells by immunoadjuvants: interactions between light density adherent and nonadherent cells in vitro.

Authors:  D S Verma; G Spitzer; A R Zander; M Beran; K A Dicke; K B McCredie
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

5.  Induction of melanoma specific monocyte cytotoxicity in patients receiving BCG immunotherapy.

Authors:  F D Dufour; D L Morton
Journal:  Surg Forum       Date:  1977

6.  The separation, long-term cultivation, and maturation of the human monocyte.

Authors:  W D Johnson; B Mei; Z A Cohn
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

7.  Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors.

Authors:  G A Currie; D W Hedley
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

8.  Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.

Authors:  G M Shaw; P C Levy; A F LoBuglio
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Activated macrophages release a factor which lyses malignant cells but not normal cells.

Authors:  G A Currie; C Basham
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

10.  Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata.

Authors:  G A Currie; S A Eccles
Journal:  Br J Cancer       Date:  1976-01       Impact factor: 7.640

View more
  2 in total

1.  Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.

Authors:  Zoya Yurkovetsky; Shlomo Ta'asan; Steve Skates; Alex Rand; Aleksey Lomakin; Faina Linkov; Adele Marrangoni; Lyudmila Velikokhatnaya; Matthew Winans; Elieser Gorelik; G Larry Maxwell; Karen Lu; Anna Lokshin
Journal:  Gynecol Oncol       Date:  2007-07-19       Impact factor: 5.482

Review 2.  The mechanisms by which polyamines accelerate tumor spread.

Authors:  Kuniyasu Soda
Journal:  J Exp Clin Cancer Res       Date:  2011-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.